MARC details
| 000 -LEADER |
| fixed length control field |
08107cam a2200721Ia 4500 |
| 001 - CONTROL NUMBER |
| control field |
on1244623089 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20220526094103.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
cr un|---aucuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
210403s2021 sz o 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9783030679897 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
3030679896 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Canceled/invalid ISBN |
9783030679880 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Canceled/invalid ISBN |
3030679888 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9783030679903 |
| Qualifying information |
(print) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
303067990X |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9783030679910 |
| Qualifying information |
(print) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
3030679918 |
| 024 7# - OTHER STANDARD IDENTIFIER |
| Standard number or code |
10.1007/978-3-030-67989-7 |
| Source of number or code |
doi |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
2901702 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCoLC)1244623089 |
| Canceled/invalid control number |
(OCoLC)1244535524 |
| -- |
(OCoLC)1253412844 |
| -- |
(OCoLC)1284936867 |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
EBLCP |
| Language of cataloging |
eng |
| Transcribing agency |
EBLCP |
| Modifying agency |
GW5XE |
| -- |
YDX |
| -- |
OCLCO |
| -- |
EBLCP |
| -- |
N$T |
| -- |
UKAHL |
| -- |
OCLCO |
| -- |
VT2 |
| -- |
LIP |
| -- |
OCLCF |
| -- |
QGK |
| 049 ## - LOCAL HOLDINGS (OCLC) |
| Holding library |
MAIN |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
RC772.V5 |
| 072 #7 - SUBJECT CATEGORY CODE |
| Subject category code |
MED044000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
| Subject category code |
MJCM |
| Source |
bicssc |
| 072 #7 - SUBJECT CATEGORY CODE |
| Subject category code |
MJCM |
| Source |
thema |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
616.2/41406 |
| Edition number |
23 |
| 245 00 - TITLE STATEMENT |
| Title |
Alternative medicine interventions for COVID-19 |
| Medium |
[electronic resource] / |
| Statement of responsibility, etc. |
Muhammad Zia-Ul-Haq, May Nasser Bin-Jumah, Sarah I. Alothman, Hanan A. Henidi, editors. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
| Place of publication, distribution, etc. |
Cham : |
| Name of publisher, distributor, etc. |
Springer, |
| Date of publication, distribution, etc. |
2021. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
1 online resource (291 p.) |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 500 ## - GENERAL NOTE |
| General note |
Therapeutic Logic of TCM as COVID-19 Inhibitor. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc. note |
References -- Chapter 5: Foods as First Defense Against COVID-19 -- Introduction -- Role of Nutrition and Diet in Prevention and Management of COVID-19 -- Prioritizing Nutrition Interventions During COVID-19 -- Grains -- Vegetables and Fruits -- Nuts -- Legumes -- Meat -- Milk and Milk Products -- Herbs -- Role of Vitamins in COVID-19 -- Vitamin A -- Vitamin B -- Vitamin C -- Vitamin D -- Vitamin E -- Role of Minerals in COVID-19 -- Iron -- Selenium -- Zinc -- Magnesium -- Role of Omega-3 Polyunsaturated Fatty Acids -- Nutrients for Immune System and Resilience in COVID-19 -- Nutrition in Lowering Stress and Depression in COVID-19 -- Food Choices for Diabetic Patients During COVID-19 -- Food Choices for Cardiovascular Patients During COVID-19 -- Food Choices for Cancer Patients During COVID-19 -- Food Choices for Patients with Digestive Disorders During COVID-19 -- Food Choices for Pulmonary Disease Patients During COVID-19 -- Malnutrition May Exacerbate COVID-19 -- Nutrition and Post-COVID Recovery -- Future Perspectives -- Conclusion -- References -- Chapter 6: Drugs for the Treatment of COVID-19 -- Introduction -- Dexamethasone -- Chloroquine -- Remdesivir -- Angiotensin-Converting Enzyme Inhibitors -- Spike Protein Inhibitors -- Conclusions -- References -- Chapter 7: COVID-19 Pandemic and Vaccines -- Introduction -- COVID-19 Vaccines: A Need of Time -- Coronavirus Vaccine Development: Challenges of the Past -- Vaccine Development Strategies -- Nucleic Acid Vaccines -- Protein Subunit Vaccines -- Inactivated or Live-Attenuated Virus Vaccines -- Virus Vector-Based Vaccines -- Repurposed Vaccines for COVID-19 and Off-Target Effects of Other Vaccines -- Plant-Based Vaccines -- Animal Models for SARS-CoV-2 Studies -- Cell Culture Systems for SARS-CoV-2 Studies -- Clinical and Immunological Endpoints -- Vaccine Development Landscape. |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Intro -- Preface -- Contents -- About the Editors -- Chapter 1: Introduction to COVID-19 -- Introduction -- Origin of COVID -- Emergence and Epidemiology -- Human-Animal Interaction as Risk Factor -- Best Suitable Animal Model -- COVID and Animal Welfare -- Molecular Differences Between Different Animal Species -- Vaccines for COVID from Animals -- Conclusion -- References -- Chapter 2: Medicinal Plants as COVID-19 Remedy -- Introduction -- Existing Plants with Potential Therapeutic Applications for Coronavirus Family (SARS-CoV) -- Plants as Specific Inhibitors of HCoV Target Proteins |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Bupleurum Species -- Artemisia annua L. -- Isatis indigotica Fortune ex Lindl. -- Alcea digitata (Boiss.) Alef. -- Lycoris radiata (L'H�er.) Herb. -- Pyrrosia lingua (Thunb.) Farw. -- Houttuynia cordata Thunb. -- Torreya nucifera L. -- Lindera aggregata (Sims) Kosterm. -- Rheum palmatum L. -- Cerasus avium (L.) Moench. -- Polygonum multiflorum Thunb. -- Citrus aurantium L. -- Rubia tinctorum L. -- Onopordum acanthium L. -- Quercus infectoria G. Olivier -- Crataegus microphylla C. Koch -- Berberis integerrima Bunge -- Alnus japonica (Thunb.) Steud. -- Paulownia tomentosa (Thunb.) Steud. |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Psoralea corylifolia L. -- Tribulus terrestris L. -- Medicinal Plants as Potential Source of Natural Antiviral Agents Against COVID -19 -- Allium Sativum (Garlic) -- Azadirachta indica (Neem) -- Curcuma domestica (Turmeric, Haldi) -- Echinacea purpurea L. (Echinacea) -- Foeniculum vulgare Mill. (Fennel) -- Glycyrrhiza glabra (Licorice) -- Melissa officinalis L. (Lemon Balm) -- Mentha piperita L. (Peppermint) -- Nigella sativa L. (Black Seeds) -- Origanum vulgare L. (Oregano) -- Ocimum bacilicum L. (Basil) -- Rosmarinus officinalis L. (Rosemary) -- Salvia officinalis L. (Sage) |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Senna alexandrina Mill. (Senna Makki) -- Zingiber officinale Rosc. (Ginger) -- Limitations -- Conclusions -- References -- Chapter 3: Traditional Chinese Medicines as Possible Remedy Against SARS-CoV-2 -- Introduction -- Traditional Chinese Medical Practices -- Laws for TCM Formulation -- Antiviral Potential of Plant Metabolites -- Structure of SARS-CoV-2 -- Relevance of SARS-CoV with SARS-CoV-2 -- Entry of SARS-CoV vs. SARS-CoV-2 into Host Cell -- TCM and SARS-CoV -- TCM and SARS-CoV-2 (COVID-19) -- Most Practiced Herbs in Formulations Against COVID-19 |
| 505 8# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Utilization Frequency of Herbs in the Formulation of (COVID-19) Decoctions -- Approved/Proposed Decoctions with Successful Clinical Trials -- Qingfei Paidu Decoction (QFPD) (Approved) -- Huashi Baidu Decoction (HBD) (Approved) -- Xiaochaihu Decoction (XCHD) -- Xuanfei Baidu Decoction (XFBD) (Approved) -- Jinhua Qinggan (JQ) (Approved) -- Huoxiang Zhengqi (HZ) Capsule -- Lianhua Qingwen (LQ) -- Xuebijing Injection (XbI) (Approved) -- Reduning Injection (RdI) -- Shufeng Jiedu Capsule (SFJC) -- Ma Xing Shi Gan Decoction (MXSGD) (Approved) -- Yin Qiao San (YQS) -- Yupingfeng San (YPFS) |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
This research volume examines the available alternative, complementary, pharmaceutical and vaccine methods for treating, mitigating, or preventing COVID-19. Coverage includes traditional Chinese medicine, herbal remedies, nutraceutical/dietary options, and drug/vaccine therapies. All the methods discussed will be critically examined to provide readers with a full, unbiased overview that includes pros/cons of each method. While the nature of COVID-19 is still being studied, and new research and theories are being published daily, this book endeavors to provide readers with a comprehensive summary of current research on alternative and mainstream treatment and prevention methods. |
| 588 0# - SOURCE OF DESCRIPTION NOTE |
| Source of description note |
Online resource; title from PDF title page (SpringerLink, viewed April 22, 2021). |
| 590 ## - LOCAL NOTE (RLIN) |
| Local note |
WorldCat record variable field(s) change: 072 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
COVID-19 (Disease) |
| General subdivision |
Alternative treatment. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Alternative medicine. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst00806153 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Behavior therapy. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst00829929 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Food |
| General subdivision |
Biotechnology. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst00930473 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Immunology. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst00968006 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Nutrition. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst01042187 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Virology. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst01167670 |
| 655 #4 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Zia-Ul-Haq, Muhammad, |
| Titles and other words associated with a name |
Ph.D. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Bin-Jumah, May Nasser. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Alothman, Sarah I. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Henidi, Hanan A. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
| Relationship information |
Print version: |
| Main entry heading |
Zia-Ul-Haq, Muhammad |
| Title |
Alternative Medicine Interventions for COVID-19 |
| Place, publisher, and date of publication |
Cham : Springer International Publishing AG,c2021 |
| International Standard Book Number |
9783030679880 |
| 850 ## - HOLDING INSTITUTION |
| Holding institution |
Faculty of Sciences and Health Technology Library |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
| Materials specified |
EBSCOhost |
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2901702">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2901702</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
National Library of Medicine Classification |
| Koha item type |
Electronic books |